1824
M. Subat, B. König
PAPER
13C NMR (100 MHz): d = 28.4 (+), 29.0 (+), 49.2 (–), 50.2 (–), 53.0
(–), 80.4 (Cquat), 111.6 (+), 122.5 (Cquat), 125.9 (Cquat), 132.1 (+),
156.3 (Cquat), 190.3 (+).
MS (ESI, 70 eV): m/z (%) = 577 (53, MH+), 599 (100, M+Na+).
HRMS: m/z calcd. for C30H48N4O7 [M]+: 576.3523. Found:
13C NMR (100 MHz): d = 21.5 (+), 21.6 (+), 51.4 (–), 51.7 (–), 51.8
(–), 52.3 (–), 107.6 (+), 112.5 (+), 127.7 (+), 128.0 (+), 129.8 (+),
129.9 (+), 133.2 (Cquat), 133.9 (Cquat), 137.7 (+), 143.9 (Cquat), 144.1
(Cquat), 147.4 (+), 158.3 (Cquat).
MS (ESI, 70 eV): m/z (%) = 712 (100, MH+).
HRMS: m/z calcd. for C34H41N5O6S3 [M]+: 711.2218. Found:
576.3516 0.6 ppm.
711.2214 0.6 ppm.
Compound 8
Isolated as the major product; yield: 151 mg (40%, 67%cbc); white
solid.
1,3-Bis(1,4,7-tris[t-butyloxycarbonyl]-1,4,7,10-
tetraazacyclododecane)-benzene (11a)
Protected azamacrocycle 1a (2 equiv, 700mg, 1.48 mmol) and aryl
halide 9b were reacted according to the general procedure A at
80 °C for 40 h with sodium t-butoxide as base and Pd(OAc)2/DPPF
as a catalyst. The major product was the dehydrohalogenation com-
pound 6a; yield: 32 mg (8%, 12%cbc); Rf = 0.61 (PE–EtOAc, 1:1).
Compound 11a was isolated as colorless, viscous oil; yield: 15 mg
(2%, 5%cbc).
Rf = 0.39 (PE–EtOAc, 1:1).
Mp 71 °C.
UV (MeCN): lmax, nm (log e) = 338 (3.162).
IR (KBr): 2978, 2934, 1696, 1641, 1166, 733 cm–1.
1H NMR (400 MHz): d = 1.30 (s, 9 H), 1.47 (s, 9 H), 1.50 (s, 9 H),
3.31–3.63 (m, 16 H), 7.34–7.41 (m, 5 H).
13C NMR (100 MHz): d = 28.3 (+), 28.4 (+), 48.1 (–), 49.0 (–), 49.3
(–), 49.7 (–), 49.9 (–), 50.3 (–), 50.7 (–), 51.3 (–), 80.0 (Cquat), 80.3
(Cquat), 80.4 (Cquat), 126.3 (+), 128.5 (+), 129.3 (+), 136.6 (Cquat),
155.5 (Cquat), 156.8 (Cquat), 157.0 (Cquat), 172.4 (Cquat).
Rf = 0.47 (PE–EtOAc, 1:1).
UV (MeCN): lmax, nm (log e) = 258 (3.879), 283 (3.458).
IR (KBr): n = 2976, 2931, 1695, 1165, 782 cm–1.
1H NMR (400 MHz): d = 1.45 (s, 36 H), 1.47 (s, 18 H), 3.38–3.45
3
MS (ESI, 70 eV): m/z (%) = 577 (25, MH+), 599 (100, M+Na+).
HRMS: m/z calcd. for C30H48N4O7 [M]+: 576.3523. Found:
(m, 32 H), 6.03 (s, 1 H), 6.17 (d, 2 H, J = 8.1 Hz), 7.07 (t, 1 H,
3J = 8.2 Hz).
13C NMR (100 MHz): d = 28.4 (+), 28.5 (+), 28.6 (+), 50.2 (–), 50.7
(–), 79.9 (Cquat), 80.0 (Cquat), 129.3 (+), 130.0 (+), 137.4 (Cquat),
156.3 (Cquat).
576.3513 0.4 ppm.
1-(2-Pyridinyl)-4,7,10-tris(t-butyloxycarbonyl)-1,4,7,10-
tetraazacyclododecane (6f)
MS (EI, 70 eV): m/z (%) = 1018 (100, M+), 57 (72).
Azamacrocycle 1a (400 mg, 0.85 mmol) and bromopyridine 5f
were reacted at 80 °C for 65 h according to the general procedure A
using Pd(OAc)2 and PPh3 as a catalyst. Compound 6f was isolated
as white solid; yield: 257 mg (55%, 89%cbc).
The m/z of the molecular ion is too high to obtain HRMS with our
instrumentation. However, the calculated and measured isotope in-
tensity patterns of the M+ peak are identical (1018 / 100%; 1019 /
62%; 1020 / 22%; 1022 / 10%).
Rf = 0.48 (PE–EtOAc, 1:1).
1,3-Bis(1,4,7-tris[t-butyloxycarbonyl]-1,4,7,10-
tetraazacyclododecane)-pyridine (11b)
Mp 58 °C.
UV (MeCN): lmax, nm (log e) = 252 (4.179), 308 (3.514).
IR (KBr): 2977, 2933, 1693, 1168, 776 cm–1.
1H NMR (400 MHz): d = 1.45 (s, 27 H), 3.21 (br s, 4 H), 3.42–3.51
(m, 8 H), 3.67 (br s, 4 H), 6.53–6.59 (m, 2 H), 7.36–7.43 (m, 1 H),
8.13 (dd, 1 H, 3J = 4.9 Hz, 4J = 1.2 Hz).
13C NMR (100 MHz): d = 28.4 (+), 28.5 (+), 50.6 (–), 51.8 (–), 79.9
(Cquat), 107.8 (+), 112.5 (+), 137.1 (+), 147.7 (+), 156.5 (Cquat),
159.3 (Cquat).
Protected azamacrocycle 1a (2 equiv, 1 g, 2.12 mmol) and bro-
mopyridine 9c were reacted according to the general procedure B at
80 °C for 62 h with sodium t-butoxide as base and Pd(OAc)2 and
PPh3 as a catalyst. Compound 12 was isolated as a side product;
yield: 81 mg (7%, 8%cbc), white solid; Rf = 0.19 (PE–EtOAc, 7:3).
Compound 11b was isolated as the major product; yield: 587 mg
(54%, 68%cbc); white solid.
Rf = 0.47 (PE–EtOAc, 1:1).
Mp 107 °C.
MS (ESI, 70 eV): m/z (%) = 550 (100, MH+).
UV (MeCN): lmax, nm (log e) = 225 (4.383), 260 (4.031), 320
Anal. Calcd for C28H47N5O6: C, 61.18; H, 8.62; N, 12.74. Found: C,
61.11; H, 8.59; N, 12.01.
(4.078).
IR (KBr): 2978, 2934, 1695, 1167, 777 cm–1.
1-Pyridine-4,7,10-tritosyl-1,4,7,10-tetraazacyclododecane (6g)
Azamacrocycle 1c (100 mg, 0.16 mmol) and bromopyridine 5f were
allowed to react according to the general procedure A at 80 °C for
144 h using Pd(OAc)2 and PPh3 as a catalyst. Compound 6g was
isolated as white solid; yield: 52 mg (46%, 60%cbc).
1H NMR (400 MHz): d = 1.45 (s, 54 H), 3.27–3.59 (m, 32 H), 5.92
(d, 2 H, 3J = 8.1 Hz), 7.23 (t, 1 H, 3J = 8.1 Hz).
13C NMR (100 MHz): d = 28.5 (+), 28.6 (+), 49.2 (–), 50.2 (–), 51.8
(–), 79.8 (Cquat), 96.1 (+), 138.6 (+), 156.4 (Cquat), 158.3 (Cquat).
MS (ESI, 70 eV): m/z (%) = 1020 (100, MH+), 1042 (37, M+Na+).
Rf = 0.31 (PE–EtOAc, 1:1).
Anal. Calcd for C51H89N9O12: C, 60.04; H, 8.79; N, 12.35. Found:
C, 59.83; H, 8.79; N, 11.86.
Mp 117 °C.
UV (MeCN): lmax, nm (log e) = 231 (4.688), 308 (3.631).
IR (KBr): 2928, 2861, 1340, 1161, 693, 550 cm–1
1H NMR (400 MHz): d = 2.43 (s, 6 H), 2.45 (s, 3H), 3.18 (br s, 4 H),
1-(3-Bromo-2-pyridinyl)-4,7,10-tris(t-butyloxycarbonyl)-
1,4,7,10-tetraazacyclododecane (10c)
Following the general procedure B, protected azamacrocycle 1a (2
equiv, 500 mg, 1.06 mmol) and bromopyridine 9c were reacted at
80 °C for 72 h with caesium carbonate as base and Pd(OAc)2 and
PPh3 as a catalyst. Compound 11b was isolated as a minor product;
yield: 61 mg (11%, 20%cbc), white solid; Rf = 0.47 (PE–EtOAc,
3
3.40–3.47 (m, 8 H), 4.00 (br s, 4 H), 6.57 (dd, 1 H, J = 6.8 Hz,
4J = 1.6 Hz), 6.84 (d, 1 H, 3J = 8.6 Hz), 7.32 (d, 6 H, 3J = 8.2 Hz),
3
4
7.47–7.53 (m, 1 H), 7.67 (dd, 6 H, J = 8.2 Hz, J = 1.7 Hz), 8.09
(dd, 1 H, 3J = 4.9 Hz, 4J = 1.4 Hz).
Synthesis 2001, No. 12, 1818–1825 ISSN 0039-7881 © Thieme Stuttgart · New York